Cyclin D1 and Ki-67 Expression Correlates to Tumor Staging in Tongue Squamous Cell Carcinoma

Overview

Journal Med Oral Patol Oral Cir Bucal

Specialty Dentistry

Date 2015 Oct 10

PMID 26449430

Citations 6

Authors

Eduardo-Pereira Guimaraes

Marina-Lara de Carli

Felipe-Fornias Sperandio

Joao-Adolfo-Costa Hanemann

Alessandro-Antonio-Costa Pereira

Affiliations

Soon will be listed here.

Abstract

Background: The immunohistochemical expression of Cyclin D1 and Ki-67 were analyzed in tongue squamous cell carcinomas (SCC), relating them to the clinical and morphological exhibition of these tumors.

Material And Methods: Twenty-nine patients fulfilled the inclusion criteria; clinical data included gender, age, ethnicity and use of licit drugs such as alcohol and tobacco. The TNM staging and histopathological differentiation grading was assessed for each case. In addition, T1 patients were gathered with T2 patients; and T3 patients were gathered with T4 patients to assemble two distinct groups: (T1/T2) and (T3/T4).

Results: The mean follow-up time was 24 months and 30% of the patients died as a consequence of the disease, while 23.3% lived with the disease and 46.7% lived lesion-free. T1 and T2 tumors showed statistically lesser Ki-67 and Cyclin D1 staining when compared to T3 and T4 tumors.

Conclusions: Ki-67 and Cyclin D1 pose as auxiliary tools when determining the progression of tongue SCC at the time of diagnosis.

Citing Articles

Cyclin D1 and Ki-67 expression and its correlation with histopathological parameters and cervical lymph node metastasis in oral squamous cell carcinoma.

Khalesi S, Maleki L, Eskandari S, Dehabadi F, Kohpaee A Dent Res J (Isfahan). 2023; 20:112.

PMID: 38020247 PMC: 10680078.

Nuclear Epidermal Growth Factor Receptor Overexpression as a Survival Predictor in Oral Squamous Cell Carcinoma.

Tarle M, Raguz M, Muller D, Luksic I Int J Mol Sci. 2023; 24(6).

PMID: 36982894 PMC: 10056291. DOI: 10.3390/ijms24065816.

Immunohistochemical study of epidermal growth factor receptor, human epidermal growth factor receptor 2/neu, p53, and Ki67 in oral squamous cell carcinoma.

Mohanapure N, Khandeparkar S, Saragade P, Gogate B, Joshi A, Mehta S J Oral Maxillofac Pathol. 2022; 26(1):127-128.

PMID: 35571320 PMC: 9106230. DOI: 10.4103/jomfp.jomfp_310_21.

A comparative study of osteopontin expression, Ki67 index and prognosis in squamous cell carcinoma and cysts of the oral cavity.

Wozniak M, Nahajowski M, Hnitecka S, Rutkowska M, Marek G, Agrawal A Transl Cancer Res. 2022; 9(2):795-808.

PMID: 35117425 PMC: 8798663. DOI: 10.21037/tcr.2019.12.08.

Immunohistochemical Expression of Cyclin D1 and Ki-67 in Primary and Metastatic Oral Squamous Cell Carcinoma.

Nazar M, Naz I, Mahmood M, Hashmi S Asian Pac J Cancer Prev. 2020; 21(1):37-41.

PMID: 31983161 PMC: 7294039. DOI: 10.31557/APJCP.2020.21.1.37.

References

Bagan J, Scully C . Recent advances in Oral Oncology 2007: epidemiology, aetiopathogenesis, diagnosis and prognostication. Oral Oncol. 2008; 44(2):103-8. DOI: 10.1016/j.oraloncology.2008.01.008. View

Goessel G, Quante M, Hahn W, Harada H, Heeg S, Suliman Y . Creating oral squamous cancer cells: a cellular model of oral-esophageal carcinogenesis. Proc Natl Acad Sci U S A. 2005; 102(43):15599-604. PMC: 1266078. DOI: 10.1073/pnas.0409730102. View

Petersen P . Oral cancer prevention and control--the approach of the World Health Organization. Oral Oncol. 2008; 45(4-5):454-60. DOI: 10.1016/j.oraloncology.2008.05.023. View

Warnakulasuriya S . Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2008; 45(4-5):309-16. DOI: 10.1016/j.oraloncology.2008.06.002. View

Marsit C, Black C, Posner M, Kelsey K . A genotype-phenotype examination of cyclin D1 on risk and outcome of squamous cell carcinoma of the head and neck. Clin Cancer Res. 2008; 14(8):2371-7. PMC: 2640470. DOI: 10.1158/1078-0432.CCR-07-4368. View

Faratzis G, Tsiambas E, Rapidis A, Machaira A, Xiromeritis K, Patsouris E . VEGF and ki 67 expression in squamous cell carcinoma of the tongue: An immunohistochemical and computerized image analysis study. Oral Oncol. 2008; 45(7):584-8. DOI: 10.1016/j.oraloncology.2008.08.002. View

Mohtasham N, Mahdavi-Shahri N, Salehinejad J, Ejtehadi H, Torabi-Parizi M, Ghazi N . Detection of nucleoproteins in squamous cell carcinoma, and dysplastic and normal mucosa in the oral cavity by methyl green-pyronin staining. J Oral Sci. 2010; 52(2):239-43. DOI: 10.2334/josnusd.52.239. View

Marocchio L, Lima J, Sperandio F, Correa L, de Sousa S . Oral squamous cell carcinoma: an analysis of 1,564 cases showing advances in early detection. J Oral Sci. 2010; 52(2):267-73. DOI: 10.2334/josnusd.52.267. View

Bello I, Soini Y, Salo T . Prognostic evaluation of oral tongue cancer: means, markers and perspectives (I). Oral Oncol. 2010; 46(9):630-5. DOI: 10.1016/j.oraloncology.2010.06.006. View

10.

Giudice F, Dal Vechio A, Abrahao A, Sperandio F, Pinto-Junior D . Different expression patterns of pAkt, NF-κB and cyclin D1 proteins during the invasion process of head and neck squamous cell carcinoma: an in vitro approach. J Oral Pathol Med. 2010; 40(5):405-11. DOI: 10.1111/j.1600-0714.2010.00960.x. View

11.

Montebugnoli L, Gissi D, Badiali G, Marchetti C, Cervellati F, Farnedi A . Ki-67 from clinically and histologically "normal" distant mucosa as prognostic marker in early-stage (T1-T2N0) oral squamous cell carcinoma: a prospective study. J Oral Maxillofac Surg. 2011; 69(10):2579-84. DOI: 10.1016/j.joms.2010.10.041. View

12.

Nguyen D, Truong P . A debate on locoregional treatment of the primary tumor in patients presenting with stage IV breast cancer. Expert Rev Anticancer Ther. 2011; 11(12):1913-22. DOI: 10.1586/era.11.168. View

13.

Henriques A, Matos F, Galvao H, Freitas R . Immunohistochemical expression of MMP-9 and VEGF in squamous cell carcinoma of the tongue. J Oral Sci. 2012; 54(1):105-11. DOI: 10.2334/josnusd.54.105. View

14.

Vieira R, Minicucci E, Marques M, Marques S . Actinic cheilitis and squamous cell carcinoma of the lip: clinical, histopathological and immunogenetic aspects. An Bras Dermatol. 2012; 87(1):105-14. DOI: 10.1590/s0365-05962012000100013. View

15.

Kovesi G, Szende B . Prognostic value of cyclin D1, p27, and p63 in oral leukoplakia. J Oral Pathol Med. 2006; 35(5):274-7. DOI: 10.1111/j.1600-0714.2006.00396.x. View

16.

Lam L, Logan R, Luke C . Epidemiological analysis of tongue cancer in South Australia for the 24-year period, 1977-2001. Aust Dent J. 2006; 51(1):16-22. DOI: 10.1111/j.1834-7819.2006.tb00395.x. View

17.

Wang L, Liu T, Nishioka M, Aguirre R, Swe Swe Win , Okada N . Activation of ERK1/2 and cyclin D1 expression in oral tongue squamous cell carcinomas: relationship between clinicopathological appearances and cell proliferation. Oral Oncol. 2006; 42(6):625-31. DOI: 10.1016/j.oraloncology.2005.11.002. View

18.

Massano J, Regateiro F, Januario G, Ferreira A . Oral squamous cell carcinoma: review of prognostic and predictive factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006; 102(1):67-76. DOI: 10.1016/j.tripleo.2005.07.038. View

19.

Reich N, Liu L . Tracking STAT nuclear traffic. Nat Rev Immunol. 2006; 6(8):602-12. DOI: 10.1038/nri1885. View

20.

Mishra A, Bharti A, Varghese P, Saluja D, Das B . Differential expression and activation of NF-kappaB family proteins during oral carcinogenesis: Role of high risk human papillomavirus infection. Int J Cancer. 2006; 119(12):2840-50. DOI: 10.1002/ijc.22262. View